Multiple Myeloma with Suspected Non-Secretory Type

Authors

  • Annisa Ginar Indrarsi Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Gadjah Mada University, Yogyakarta
  • Usi Sukorini Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Gadjah Mada University, Yogyakarta

DOI:

https://doi.org/10.24293/ijcpml.v27i1.1575

Keywords:

Multiple myeloma non-secretory, hypogammaglobulinemia

Abstract

Multiple Myeloma (MM) is a hematological malignancy characterized by clonal plasma cell in bone marrow that produce abnormal globulin, which resulted in monoclonal gammopathy. Multiple Myeloma Non-Secretory (MMNS) is a very rare form of multiple myeloma with monoclonal plasmocytic proliferation in bone marrow supported by clinical manifestation and radiological findings. However, plasma cells fail to secrete immunoglobulin. A 44-year-old female came to Sardjito General Hospital with main complaints of weakness and back pain. General weakness and pale palpebral conjunctiva were 6 observed (+/+), liver and spleen were not palpable. Blood test results were as follows: Hb 3.0 g/dL, RBC 1.07 x 10 / μL, WBC 3 3 562 x 10 /μL, PLT 114 x 10 /μL, A/G ratio 1.07, BUN 51.5 mg/dL, creatinine 4.62 mg/dL, and calcium 3.1 mmol/L. Skeletal survey suggested a multiple osteolytic. Protein electrophoresis revealed hypogammaglobulinemia with no M-spike. There were 66% of plasma cells in bone marrow. Patient was diagnosed by MMNS. Diagnosis MMNS can be established if clonal plasmacytes is accompanied with renal insufficiency and hypercalcemia. However, monoclonal gammopathy was not found in serum protein electrophoresis. A case reported of 44-year-old female diagnosed as MMNS with 'punched out' multiple osteolytic, increased plasma cells in bone marrow without evidence of paraprotein in circulation proved by low A/G ratio and negative M-spike.

Downloads

Download data is not yet available.

Author Biographies

Annisa Ginar Indrarsi, Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Gadjah Mada University, Yogyakarta

Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine,  Gadjah Mada University, Yogyakarta

Usi Sukorini, Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Gadjah Mada University, Yogyakarta

Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine,  Gadjah Mada University, Yogyakarta

References

Lonial BS, Kaufman JL. Non-secretory myeloma: A clinician ' s guide Review, 2019; 4-7.

Wei A. Bone marrow immunohistology of plasma cell neoplasms. J Clin Pathol, 2003; 56(6): 406-11.

Aman AK. Profil penderita multiple myeloma di bagian Patologi Klinik FK USU/RSUP H. Adam Malik Medan. Maj Kedokt Nusant. 2005; 38(2): 176-9.

Ludwig H, Bolejack V, Crowley J, Bladé J, San Miguel J, et al. Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol, 2010; 28(9): 1599-605.

Whicher JT, Davies JD, Grayburn JA. Intact and fragmented intracellular immunoglobulin in a case

of non secretory myeloma. J Clin Pathol, 1975; 28(1): 54-9.

Middela S, Prakash K. Non-secretory multiple myeloma. Arch Pathol Lab Med, 2009; 43(4): 408-11.

Palumbo A, Anderson K. From multiple myeloma. N Engl J Med, 2010; 1-11.

Sharma A, Kaushal M, Chaturvedi NK, Yadav R. Cytodiagnosis of multiple myeloma presenting as

orbital involvement: A case report. Cyto Journal, 2006; 3: 1-5.

Prasad R, Yadav RR, Singh A, Mathur SP, Mangal Y, Singh M. Non-secretory multiple myeloma presenting with diffuse sclerosis of affected bones interspersed with osteolytic lesions. Br J Radiol, 2009; 82(974): 29-31.

C a l d a s . N o n - s e c r e t o r y m y e l o m a o r l i g h t chain-producing multiple myeloma: A case report. J Med Cases, 2011; 2(3): 97-100.

Kyle RA, Rajkumar S V. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia, 2009; 23(1): 3-9.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol [Internet]. 2014;15(12):

e538-48. Available from: http://dx.doi.org/10.1016/S1470-2045(14)70442-5 (accessed 7 October, 2019).

Dupuis MM, Tuchman SA. Non-secretory multiple myeloma: From biology to clinical management. Onco Targets Ther, 2016; 9: 7583-90.

Corso A, Mangiacavalli S. Review articles non-secretory myeloma: Ready for a new definition?.

Mediterr J Hematol Infect Dis [Internet]. 2017; 9(Mc): 2017053. Available from: www.mjhid.org (accessed 24 June, 2019).

Maimun Zulhaidah Arthamin, Nyi R. Wahidah BAS. Myeloma multiple non-secretory. Clin Pathol and Med Lab, 2012; 22(1): 99-103.

Downloads

Submitted

2019-11-08

Accepted

2020-09-03

Published

2020-12-07

How to Cite

[1]
Indrarsi, A.G. and Sukorini, U. 2020. Multiple Myeloma with Suspected Non-Secretory Type. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 27, 1 (Dec. 2020), 104–109. DOI:https://doi.org/10.24293/ijcpml.v27i1.1575.

Issue

Section

Case Report